Appropriate use of sound science applied at critical junctures will improve efficiency in the high-wire act of drug development. Pharmaceutical companies walk a tightrope in early drug development.

The United Kingdom’s Center for Process Innovation (CPI) is investing in a new project, Microstar, which seeks to reduce risk for formulators through the development of accelerated screening methods ...

Protein drug formulation is particularly challenging due to structural complexity and instability. ProJect Pharmacueticals has unveiled its approach for a rational design of optimized ...

The course consists of four days of lecture-based coverage of topics in Lean, Six-Sigma, and two days of individual hands-on, on-site project formulation and guidance resulting in significant ...

Formulation is arguably the most critical—and challenging—component of biopharmaceutical drug development, second only to the molecule itself. Formulation’s far-reaching consequences help sponsors ...